Study shows mouthwash can kill Covid virus in saliva
MOUTHWASH can kill Covid in saliva, a new study by researchers at Cardiff University has shown. The small trial of patients found some types of mouthwash eliminated the virus in saliva by 99.8%.
In the trial, 27 hospital patients with PCR-confirmed Covid-19 were given one of four different types of oral rinse, including two containing cetylpyridinium chloride (CPC), one containing povidone-iodine and another containing saline.
Cetylpyridinium chloride (CPC) is used in some types of mouthwashes, toothpastes, lozenges, throat sprays, breath sprays, and nasal sprays. It is an antiseptic that kills bacteria and other microorganisms. The most effective contained CPC and isopropyl myristate – a single 30-second rinse with this formulation in seven patients eliminated the virus in the saliva by 99.99% at one minute, and by 99.8% at 60 minutes. In three of the seven patients (around 40%) no live virus was detected in the saliva at any time after the initial rinse.
Other formulations containing compounds such as povidone-iodine or saline had little to no effect, while the rinse containing CPC and benzoate did not show a persistent effect, suggesting formulation is “critical”, said the researchers.
Scientists from Cardiff University detailed the molecular make-up of the fatty outer envelope of the Covid virus for the first time- and say it could prove an important new target for antivirals.
The mouthwash trial was done as part of work by the scientists involved which revealed the make up of the SARS-CoV-2 “outer envelope”. Researchers said their study shows the little-understood lipid envelope could be antiviral target in the mouth.
Study of the viral lipid envelope showed it had significant differences to healthy host cell membranes, suggesting the potential for it to be selectively targeted, said the research, which has been published in the Journal of Lipid Research.
“While vaccines and antivirals have targeted proteins or the replication cycle of SARS-CoV-2, there has been little research into the lipid envelope to date,” said Professor Valerie O’Donnell, a lipid biochemist and coauthor on the study from Cardiff University’s School of Medicine.
“Our study has mapped this essential viral component. Addressing this knowledge gap could enable selective therapeutic targeting that avoids damaging host membranes. We also suspect the membrane won’t be impacted by mutation of the virus, unlike spike proteins.”
The Cardiff team created a detailed “map” of the little-understood lipid envelope and found it contained very little cholesterol, unlike host cell membranes. “The findings suggest there is potential to target the virus in the oral cavity with therapeutics without collateral damage to the body’s own cells,” researchers said .
As part of the same study, they carried out the small-scale clinical trial in Covid patients to test whether oral rinses containing lipid disrupting chemicals called surfactants could reduce infectivity in the mouth.